Aileron Therapeutics (ALRN) IPO Opens Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- Mahindra & Mahindra Ltd (MM:IN) (MAHMF) PT Raised to INR320 at HSBC
- HSBC Downgrades Shriram Finance Ltd (SHFL:IN) to Hold
- UK budget airline easyJet ready to accept $7.3 billion takeover bid from Castlelake
- Citi Adds Micron Technology (MU) to 90-Day Upside Catalyst Watch List
- Strategy reports $8.32B bitcoin loss and sells BTC to fund dividends
Aileron Therapeutics Announces Pricing of Initial Public Offering
June 28, 2017 10:06 PM EDTCAMBRIDGE, Mass., June 28, 2017 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a novel class of therapeutics called stapled peptides for cancers and other diseases, today announced the pricing of its initial public offering of 3,750,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts and commissions. All of the shares are being offered by Aileron. In addition, Aileron has granted the underwriters a 30-day option to purchase up to an additional 562,500 shares of common stock from the company at the public offering price. Ailerons common stock is... More
